Schmidt J B, Lindmaier A, Trenz A, Schurz B, Spona J
Department of Dermatology II, University of Vienna, Austria.
Gynecol Obstet Invest. 1991;31(4):235-9. doi: 10.1159/000293166.
Reports on hormone analysis in androgenic hairloss in the female show partly contradicting results. Elevated as well as normal-range androgen levels have been found. The present study aimed at the investigation of a possibly more differentiated hormonal constellation by hormone analysis and additional determination of the hypophyseal level by the thyrotropin-releasing hormone (TRH) test. In 46 female patients with androgenic hairloss blood sampling for hormone analysis was performed. Determination of the androgens testosterone (T), androstenedione (A), dehydroepiandrosterone sulfate (DHEAS), 17-hydroxy-progesterone acetate (17-OHP) and free testosterone (FT), of sex-hormone-binding globulin (SHBG), estradiol (E2), cortisol (F) and the hypophyseal luteinizing hormone (LH) and follicle-stimulating hormone (FSH) was performed by standard radioimmunoassay methods. The TRH-test is based on feedback mechanisms between the hypothalamic TRH which stimulates hypophyseal TSH and PRL release. Thus, even mild forms of hypothyroidism or hyperprolactinaemia can be detected. The control group for the TRH test consisted of 45 volunteer females without hairloss or any other hormonal or menstrual disturbances. Statistical analysis was performed according to the Wilcoxon two-sample test. The results of the study show no significant elevation of androgens in females with androgenic hairloss, but a more complex condition with involvement of the glandula suprarenalis and the hypophyseal level. Significantly elevated TSH levels prior to and after TRH stimulation in the hairloss group indicate that hypothyroidism may be an important hormonal disturbance in androgenic hairloss. Interactions between hypothyroidism and androgen metabolism are possible at various links.(ABSTRACT TRUNCATED AT 250 WORDS)
关于女性雄激素性脱发的激素分析报告显示,结果部分相互矛盾。已发现雄激素水平升高以及处于正常范围的情况。本研究旨在通过激素分析以及通过促甲状腺激素释放激素(TRH)试验额外测定垂体水平,来研究可能更具差异性的激素状态。对46名患有雄激素性脱发的女性患者进行了用于激素分析的血液采样。采用标准放射免疫测定方法测定雄激素睾酮(T)、雄烯二酮(A)、硫酸脱氢表雄酮(DHEAS)、17 - 羟孕酮醋酸酯(17 - OHP)和游离睾酮(FT)、性激素结合球蛋白(SHBG)、雌二醇(E2)、皮质醇(F)以及垂体促黄体生成素(LH)和促卵泡生成素(FSH)。TRH试验基于下丘脑TRH刺激垂体促甲状腺激素和催乳素释放之间的反馈机制。因此,即使是轻度的甲状腺功能减退或高泌乳素血症也能被检测到。TRH试验的对照组由45名无脱发或任何其他激素或月经紊乱的志愿者女性组成。根据威尔科克森两样本检验进行统计分析。研究结果表明,患有雄激素性脱发的女性雄激素水平没有显著升高,但存在一种更复杂的情况,涉及肾上腺和垂体水平。脱发组在TRH刺激前后促甲状腺激素水平显著升高,表明甲状腺功能减退可能是雄激素性脱发中一种重要的激素紊乱。甲状腺功能减退与雄激素代谢之间可能在多个环节存在相互作用。(摘要截断于250字)